n. 1 junior grant:“Assessment of anti-cancer therapy using immunocytokines and immune checkpoint inhibitors combined with oncosuppressor RNASET2 in immunocompetent mouse models” (dbsv2023-adrj002)
n. 1 junior grant:“Assessment of anti-cancer therapy using immunocytokines and immune checkpoint inhibitors combined with oncosuppressor RNASET2 in immunocompetent mouse models” (dbsv2023-adrj002)
A selection procedure by qualifications is hereby opened for the assignment of n. 1 junior research grants with a duration of 1 year.
Research Title: “Assessment of anti-cancer therapy using immunocytokines and immune checkpoint inhibitors combined with oncosuppressor RNASET2 in immunocompetent mouse models”.
All the details in the announcement.
Calling Code: dbsv2023-adrj002
Official Publication Date: September 25 2023
Published on the MIUR website: September 25 2023